SCHEMBL29487294

SCHEMBL29487294

CCCCOC(=O)N1CC[C@@H](n2c(=O)[nH]c3c(N(Cc4ccccc4)Cc4ccccc4)ncnc32)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 4/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ CHRM5 P08912 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ BCHE P06276 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ OPRD1 P41143 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GPR119 Q8TDV5 1/20 0.36
▸ LCK P06239 2/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ TLR7 Q9NYK1 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15171143 0.86 JAK2 (0.49) BTKGPR119JAK2JAK1
SCHEMBL15711178 0.86 JAK2 (0.49) BTKGPR119JAK2JAK1
SCHEMBL16143648 0.86 PIK3CD (0.38) BTKBCHEACHETSHROPRK1
SCHEMBL20480742 0.86 PIK3CD (0.38) BTKBCHEACHETSHROPRK1
SCHEMBL15171260 0.82 HTR6 (0.46) BTKBCHEGPR119JAK2JAK1
SCHEMBL16341186 0.82 HTR6 (0.46) BTKBCHEGPR119JAK2JAK1
SCHEMBL15155889 0.81 EGFR (0.39) BTKTSHRSMN1; SMN2LCKKDM4E
SCHEMBL14797959 0.80 JAK1 (0.42) ACHEGPR119JAK2JAK1
SCHEMBL31626148 0.80 JAK1 (0.42) ACHEGPR119JAK2JAK1
SCHEMBL30760906 0.78 JAK2 (0.44) BTKGPR119JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11292795-B2 Purinone derivative hydrochloride ONO PHARMACEUTICAL CO., LTD. (JP) 2022-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11292795-B2 Purinone derivative hydrochloride BTK, P2RY1, P2RY13 BTK 1/4885CHRM2 3829/4885CHRM4 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback